Literature DB >> 22318743

Reduced bone mineral density in patients with haemophilia A and B in Northern Greece.

Panagiotis Anagnostis1, Sofia Vakalopoulou, Aristidis Slavakis, Maria Charizopoulou, Eirini Kazantzidou, Tania Chrysopoulou, Timoleon-Achilleas Vyzantiadis, Eleni Moka, Alexandra Agapidou, Vassilia Garipidou.   

Abstract

Haemophilia A and B has been associated with increased prevalence of low bone mass (67-86%). The aim of this study was to estimate the prevalence of bone disease in haemophiliacs and its association with potential risk factors. Adult patients with haemophilia A and B followed-up in the Haemophilia Centre of Northern Greece were included. Bone mineral density (BMD) was measured by dual-energy X-ray absorptiometry (DXA) in lumbar spine (LS), femoral neck (FN), total hip (TH) and great trochanter (GT). One-hundred four male patients (aged 45.8 ± 15.1 years) and 50 controls (aged 44.9 ± 12.8 years) were screened. Low BMD was diagnosed in 28 patients (26.9%) and 10 controls (20%) (p=0.0001). Patients had lower BMD in TH (p=0.007), FN (p=0.029) and GT (p=0.008) than controls, without differences in LS. BMD was positively associated with the severity of haemophilia, history of herpes virus C or human immunodeficiency virus and level of physical activity, and negatively with the level of arthropathy. In multiple-regression analysis, only the level of physical activity and 25-hydroxyvitamin D [25(OH)D] significantly predicted BMD. Half of the patients had vitamin D deficiency. In conclusion, our study showed increased prevalence of low BMD in haemophiliacs. The levels of physical activity and 25(OH)D independently predicted low BMD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22318743     DOI: 10.1160/TH11-08-05563

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  17 in total

1.  Evaluation of bone mineral density and related parameters in patients with haemophilia: a single center cross-sectional study.

Authors:  Hatice Demet Kiper Unal; Melda Comert Ozkan; Fatos Dilan Atilla; Zuhal Demirci; Nur Soyer; Ilgin Yildirim Simsir; Ozgur Omur; Kazim Capaci; Guray Saydam; Fahri Sahin
Journal:  Am J Blood Res       Date:  2017-11-01

2.  Evaluation of bone mineral density (BMD) and indicators of bone turnover in patients with hemophilia.

Authors:  Mehmet Dagli; Ali Kutlucan; Sedat Abusoglu; Abdulkadir Basturk; Mehmet Sozen; Leyla Kutlucan; Ali Unlu; Farise Yilmaz
Journal:  Bosn J Basic Med Sci       Date:  2018-05-20       Impact factor: 3.363

3.  Bone density in haemophilia: a single institutional cross-sectional study.

Authors:  C L Kempton; A Antun; D M Antoniucci; W Carpenter; M Ribeiro; S Stein; L Slovensky; L Elon
Journal:  Haemophilia       Date:  2013-08-01       Impact factor: 4.287

4.  Joint bleeding in factor VIII deficient mice causes an acute loss of trabecular bone and calcification of joint soft tissues which is prevented with aggressive factor replacement.

Authors:  A G Lau; J Sun; W B Hannah; E W Livingston; D Heymann; T A Bateman; P E Monahan
Journal:  Haemophilia       Date:  2014-04-08       Impact factor: 4.287

Review 5.  Bone mineral density in men and children with haemophilia A and B: a systematic review and meta-analysis.

Authors:  S A Paschou; P Anagnostis; S Karras; C Annweiler; S Vakalopoulou; V Garipidou; D G Goulis
Journal:  Osteoporos Int       Date:  2014-07-08       Impact factor: 4.507

6.  Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF-α pathway.

Authors:  Coline Haxaire; Narine Hakobyan; Tania Pannellini; Camila Carballo; David McIlwain; Tak W Mak; Scott Rodeo; Suchitra Acharya; Daniel Li; Jackie Szymonifka; Xiangqian Song; Sébastien Monette; Alok Srivastava; Jane E Salmon; Carl P Blobel
Journal:  Blood       Date:  2018-05-18       Impact factor: 22.113

Review 7.  Hematological Diseases and Osteoporosis.

Authors:  Agostino Gaudio; Anastasia Xourafa; Rosario Rapisarda; Luca Zanoli; Salvatore Santo Signorelli; Pietro Castellino
Journal:  Int J Mol Sci       Date:  2020-05-16       Impact factor: 5.923

8.  Clinical Care of Bone Health in Patients on the Immune Tolerance Induction's Protocols With an Immunosuppressive Agent for Inhibitor Eradication in Hemophilia.

Authors:  Zahra Rezaieyazdi; Hassan Mansouritorghabeh
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

9.  Serum Concentrations of Vitamin D, Calcium, Phosphorus and Trace Minerals in Adults and Children with Haemophilia A: Association with Disease Severity, Quality of Life, Joint Health and Functional Status.

Authors:  Amir Abbasnezhad; Mehdi Habibi; Babak Abdolkarimi; Soodabeh Zare; Ezatollah Fazeli Moghadam; Razieh Choghakhori
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2020-01-01

10.  Bone health in symptomatic carriers of haemophilia A: a protocol for a multicentre prospective matched-cohort study.

Authors:  Grace H Tang; Erin Norris; Jessica Petrucci; Paula D James; Adrienne Lee; Man-Chiu Poon; Georgina Floros; Laurence Boma-Fischer; Jerry Teitel; Rosane Nisenbaum; Michelle Sholzberg
Journal:  BMJ Open       Date:  2019-12-02       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.